Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Systems Biology|October 25, 2021
Metabolic requirements of the metastatic cascadeStanislav Drapela, Ana P Gomes
Molecular Oncology|June 6, 2022
Metabolic reprogramming: a bridge between aging and tumorigenesisStanislav Drapela, Didem Ilter, Ana P Gomes
STAR Protocols|October 31, 2025
Protocol for the utilization of murine interstitial fluid extract to model breast cancer in the context of old age in vitroStanislav Drapela, Rojan Chimeh Rad, Didem Ilter, et al.
Trends in Cancer|November 7, 2024
Metabolic landscape of disseminated cancer dormancyStanislav Drapela, Bruna M Garcia, Ana P Gomes, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Aging directs the differential evolution of KRAS-driven lung adenocarcinomaFelicia Lazure, Stanislav Drapela, Xiaoxian Liu, et al.
Redox Biology|February 25, 2023
NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasisDidem Ilter, Stanislav Drapela, Tanya Schild, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.
Oncogene|October 30, 2024
Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8<sup>+</sup> T cells to suppress anti-tumor immunityJoanne D Tejero, Rebecca S Hesterberg, Stanislav Drapela, et al.
Haematologica|April 13, 2019
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cellsMiroslav Boudny, Jana Zemanova, Prashant Khirsariya, et al.
Cancer Research|May 15, 2025
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis InitiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.
Pageof 2